Zhaozhen Wu

Years Active: 2020-2021
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Zhaozhen Wu, Haitao Tao, Sujie Zhang, Xiao Wang, Junxun Ma, Ruixin Li, Zhefeng Liu, Jinliang Wang, Pengfei Cui, Shixue Chen, Huang Di, Ziwei Huang, Xuan Zheng, Yi Hu
Efficacy and safety of anti-PD-1-based therapy in combination with PARP inhibitors for patients with advanced solid tumors in a real-world setting. Cancer immunology, immunotherapy : CII 70 (10) (2021)
Zhaozhen Wu, Pengfei Cui, Haitao Tao, Sujie Zhang, Junxun Ma, Zhefeng Liu, Jinliang Wang, Yuanyu Qian, Shixue Chen, Ziwei Huang, Xuan Zheng, Di Huang, Yi Hu
The Synergistic Effect of PARP Inhibitors and Immune Checkpoint Inhibitors. Clinical Medicine Insights. Oncology 15 (2021)
Pengfei Cui, Di Huang, Zhaozhen Wu, Haitao Tao, Sujie Zhang, Junxun Ma, Zhefeng Liu, Jinliang Wang, Ziwei Huang, Shixue Chen, Xuan Zheng, Yi Hu
Association of immune-related pneumonitis with the efficacy of PD-1/PD-L1 inhibitors in non-small cell lung cancer. Therapeutic advances in medical oncology 12 (2020)

Zhaozhen Wu.css-eqlu8i{font-size:small;padding-left:4px;}